Log In
BCIQ
Print this Print this
 

dalcetrapib (JTT-705, R1658, RG1658)

  Manage Alerts
Collapse Summary General Information
Company Japan Tobacco Inc.
DescriptionSmall molecule inhibitor of cholesteryl ester transfer protein (CETP)
Molecular Target Cholesteryl ester transfer protein (CETP)
Mechanism of ActionCholesteryl ester transfer protein (CETP) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationAcute coronary syndrome
Indication DetailsTreat acute coronary syndrome
Regulatory Designation
PartnerDalCor Pharma U.K. Ltd.;
Torii Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/09/2015

Undisclosed

Undisclosed

Undisclosed

06/08/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today